Fresenius Medical Care (FMS), a leading provider of dialysis products and services, reported fourth-quarter and fiscal 2010 earnings per ADS of 90 cents and $3.25, respectively, beating the corresponding Zacks Consensus Estimates of 88 cents and $3.23 while exceeding the year-ago earnings of 82 cents and $2.99. Net income (attributable to the company) climbed 10% year over year to $271.4 million, in the fourth quarter, riding on higher sales.
he US Department of Energy (DOE) finalized a $96.8 million Recovery Act supported loan guarantee to a project sponsored by US Geothermal, Inc. to construct a 23 megawatt (net) geothermal power project in Malheur County, in southeastern Oregon. DOE initially offered a $102.2-million conditional commitment for the project in June 2010.
Shares of SciQuest, Inc. (NASDAQ:SQI) are trading up 0.00% as of Feb 23, 4:00PM EST, hitting . SciQuest, Inc. has a 52 week low of 10.50 and a 52 week high of 15.79. The companies last released earnings were 1.02 per share. were The company has a market cap of 283.29M and a price-to-earnings ratio of 13.55.
Shares of Volcano Corporation (NASDAQ:VOLC) are trading down -0.48% as of Feb 24, 10:13AM EST, hitting 27.35. Volcano Corporation has a 52 week low of 20.11 and a 52 week high of 29.08. The companies last released earnings were -0.12 per share. were The company has a market cap of 1.38B and a price-to-earnings ratio of .
SPEX lost 6.13% to $0.920. Spherix Incorporated operates in two segments: Biospherics and Health Sciences.The stock opened at $0.99 and is trading within the range of $0.90-$1.09.
VVUS surged 1.36%, to close at $11.20 and its overall traded volume was 2.35M shares on Friday 14th January, 2010, against its average volume of 3.03M. VVUS shares were trading within the range of $10.81-$11.31 while its opening price was $11.06
Year over year, VIVUS Inc. has seen revenues fall from $102.2M in 2008 to $50.0M in 2009. SGA costs have also rose leading to a reduction in the bottom line from a loss of $9.9M in 2008 to an even larger loss of $54.3M in 2009.However, Vivus has seen an increase in its share price owing to the success of its drug Avanafil. Vivus’ stock ended at $10.67 up by 0.28% in the last trading day.
Blue Nile traded in a range yesterday that spanned from a low of $57.55 to a high of $58.46. Yesterday, the shares gained 0.54%, which took the trading range above the 3-day high of $58.03 on volume of 150,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DNDN surged up 1.07% to $36.99 after the Company announced that it plans to offer $500 million aggregate principal amount of convertible senior notes due January 15, 2016 in a registered offering.
NILE surged by 8.53% and are presently trading at a change of 9.73% from its close on the last trading session and 8.53% from its open today morning. The stock has traded with a volume of 522394 compared to its average trading volume of 239.94K shares. The RSI stands at 76.07 while the ROA and ROE are 16.04% and 38.05% respectively.
The substantial increase in revenue is attributed toward the payment from covidien of $40.0 million which comes from FDA approval of Exalgo. However the company reports the net loss of $3.1 million as per financial statements ending March 31st, 2010 resulting in negarive earning per share of $0.05 which again is a far better position if compared with net loss of $8.5 million in the first quarter of year 2009 which resulted in negative earning per share of $0.24.Stock compensation in the latest financial statements arrives at $1.6 million as compared to $1.3 million in the first quarter of year 2009. Total cash and cash equivalents surged up to $55.23 million from $25.9 million as on December 31st, 2009 depicting the change of more than 50 percent.http://www.favstocks.com/forum/hot-stocks/692-crxx-combinatorx-inc.html
A new Renewable Energy Law took effect January 1, 2010 and the government announced a goal of having 10 percent of the country`s gross energy consumption be renewable by 2020. This is a huge increase from the current 1 percent. Renewable energies such as wind, solar, and biofuels are expected to grow into a $100 billion market over the next 15 years in China, making it a globalpowerhouse in renewables. company has established numerous production and sales bases
nationwide.and has the capability of producing 300,000 tons of alcohol
based fuels annually. http://www.favstocks.com/forum/hot-stocks/1916-trit-tri-tech-holding-inc-nasdaq-stock.html
Labopharm is headquartered in Laval, Canada with U.S. offices in Princeton, New Jersey. The company is focused on optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The company's lead product, a unique once-daily formulation of tramadol, is available in 19 countries around the world, including the U.S., Canada, major European markets and Australia.Labopharm plans to sign a marketing partner for trazodone after it receives FDA approval. “We are comfortable with that,” Mr. Howard-Tripp says, adding that launch preparations and planning have been underway for well over a yearhttp://www.favstocks.com/forum/hot-stocks/1609-ddss-labopharm-nasdaq.html
The Company seeks to acquire equity participation in pre-IPO and early-stage resource companies where it can provide value-added managerial and board-level advisory services as well as financial support. the global mining industry are now on a sounder footing. Although commodity prices are not expected to rise significantly in 2010 as they did in 2009, they should continue to have moderate growth, fuelled by continued strong demand from China and sustained recovery in industrial countries. In this environment, we expect that the demand for financing of new mining projects will continue to grow, providing opportunities for Aberdeen International to provide funding for new small-cap resource companies.http://www.favstocks.com/forum/hot-stocks/1512-tse-aab.html
The Company has developed a proprietary medical technology designed to produce 3D medical diagnostic images in real time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. IMGG is also a remanufacturer of C-arms. The Company offers new, demonstration, remanufactured, refurbished and pre-owned systems in all price ranges from every manufacturer, including OEC, General Electric (GE), ISI, Philips, Siemens, FluoroScan, XiScan and Ziehm. The Company supplies full-size, compact and mini C-arms. It also supplies pain management tables, urology tables and vascular tables.http://www.favstocks.com/forum/hot-stocks/992-imgg-imaging3-inc.html
the exclusive worldwide license in perpetuity to market, manufacture and sell ReddiForm Insulated Concrete Forms ("ICFs"), a green patented building product that allows for reduced energy costs while providing more economies and efficiencies in the construction process for homes, industrial and commercial buildings.Alternative Green Technologies (Pink Sheets: AGTI) is a public company focused on the commitment to reduce the carbon footprint in the world by acquiring and building companies that help the environment in reducing carbon emissions in addition to reducing worldwide energy costs and waste.http://www.favstocks.com/forum/hot-stocks/1681-agti.html
The firm's investigation concerns potentially false and misleading statements made by XenoPort and certain officers and directors in connection with Horizant, a drug treatment for Restless Leg Syndrome. XNPT stock fell 66% to close at $6.67 on February 18, 2010 after it was revealed the FDA was delaying approval of Horizant for a second time due to findings that the drug had caused pancreatic cancer cells to form in lab rats.Kendall Law Group has the credentials and experience to pursue any type of complex securities litigation in the nation. The firm led by former federal judge and former U.S. Attorney, is a national securities firm that represents shareholders when publicly traded companies violate the law. Shareholders who purchased XNPT common stock before or during the relevant period may have a claim against the company and are urged to contact attorney Scott Kendall for more information.http://www.favstocks.com/forum/hot-stocks/1725-xnpt-xenoport-inc-nasdaq.html
Cardium Therapeutics Inc. Announces $6.0 Million Registered Direct Offering
Thursday, 15 Oct 2009 09:15am EDT
Cardium Therapeutics Inc. announced a registered direct offering of common stock to selected investors for aggregate gross proceeds of $6.0 million. The securities in the offering include an estimated 4,615,385 shares of Cardium common stock at a price of $1.30 and warrants to purchase up to 3,000,000 shares of Cardium common stock at an exercise price of $1.40. The warrants are exercisable six months after the date of issuance, and will expire six years from the date they are first exercisable. Dawson James Securities acted as exclusive placement agent for the offering.The company is focused on developing disease modifying therapeutics for the treatment of common neurological disorders, particularly Alzheimer's, Parkinson's and Huntington's disease.http://www.favstocks.com/forum/hot-stocks/1685-cxm-fda-approval.html
I believe that this company has the potential for much higher valuation and their growth prospects, as I understand it, have the company,already profitable monthly (listed only since mid March 2009), is increasing revenues some 15 to 20 times over the next 24 months without factoring in what will almost certainly be a rising market for oil and gas over the same period. The Prospect, located in northern Oklahoma, has potential for high gravity light oil above 3800 feet and if successful, wells could produce in the 150 BPD range as anticipated Initial Production Rates. The play has the potential for a multi-well program on 40 acre spacing should the test well prove to be a success. Operations on-site have commenced with road construction and site preparations currently underway, and the Company has been advised that a spud date is predicted within several days subject to the impending arrival of the drilling rig.http://www.favstocks.com/forum/hot-stocks/1406-aaph-american-petro-hunter-otcbb.html
ImmuneRegen has previously reported on the effects of Homspera on the differentiation of human adult stem cells, particularly into hematopoietic stem cells that are capable of becoming blood cells and are the foundation of the body's immune system. Very small embryonic-like stem cells are also found in adults but may have broader applications and are morphologically closer to embryonic stem cells in their potential. NeoStem has the ability to harvest very small embryonic-like stem cells from individual patients, representing a significant step toward overcoming the two major limitations in the development of stem cell therapies today -- the ethical dilemma regarding use of embryonic stem cells, and the immunological problems associated with using cells from a donor.http://www.favstocks.com/forum/hot-stocks/69-nbs-future-insurance.html